In agreement with our speculation, Wang et al. (2014) have reported that peritoneal injection of siRNA specific to HDAC4 could also suppress podocyte injury and ameliorate diabetic nephropathy in a murine model. This evidence concerns the gene HDAC4 and diabetic kidney disease.